In light of Merck "'s" withdrawal of Vioxx from the market and other recent news stories examining FDA "'s" review of the safety and efficacy of anti-depressant drug use by children, I am concerned whether FDA has been sufficiently aggressive in monitoring drug safety, "" " Davis wrote.
And researchers writing in the New England Journal of Medicine voiced their concerns as well with such drugs as Pfizer "'s" popular Celebrex.
